Spurred by the growth in the biopharmaceutical sector in Asia and the demand for higher quality, established and credible conferences to this region, Cambridge Health Institute will launch its first Asia PEGS Summit in China in April. The event will focus on topics of greater relevance and interest to the China/Asia biopharmaceutical industry, including protein and antibody engineering, protein expression, analytical techniques and CMC strategies.